Tanja Schneider‐Merck

Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage

Tanja Schneider‐Merck, Jeroen J. Lammerts van Bueren, Sven Berger et al. · The Journal of Immunology · 2009 · 216 citations · Full text

Immune Regulation, Immunology, Cell Death +20

Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells

Matthias Peipp, Jeroen J. Lammerts van Bueren, Tanja Schneider‐Merck et al. · Blood · 2008 · 214 citations · Full text

Immunotoxicology, Immunology, Immune Regulation +16

Cyclic AMP-induced Forkhead Transcription Factor, FKHR, Cooperates with CCAAT/Enhancer-binding Protein β in Differentiating Human Endometrial Stromal Cells

Mark Christian, Xiaohui Zhang, Tanja Schneider‐Merck et al. · Journal of Biological Chemistry · 2002 · 180 citations · Full text

Molecular Regulation, Gynecology, Decidual Transformation +16

Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies

Michael Dechant, Wencke Weisner, Sven Berger et al. · Cancer Research · 2008 · 162 citations

Effector Mechanisms of Recombinant IgA Antibodies against Epidermal Growth Factor Receptor

Michael Dechant, Thomas Beyer, Tanja Schneider‐Merck et al. · The Journal of Immunology · 2007 · 89 citations · Full text